Chen Y S, Ko W J, Lin F Y, Huang S C, Chou T F, Chou N K, Hsu R B, Wang S S, Chu S H
Department of Cardiothoracic Surgery, National Taiwan University Hospital, Taipei, Taiwan.
J Heart Lung Transplant. 2001 Aug;20(8):850-7. doi: 10.1016/s1053-2498(01)00267-4.
Extracorporeal membrane oxygenation (ECMO) is not suitable for long-term support because of its high incidence of complications. Conversion from ECMO to ventricular assist device (VAD) is reasonable, and we have developed a simple algorithm for selecting proper VADs for these ECMO-supported patients.
We converted 12 patients who were receiving ECMO support to VAD for bridge to transplantation. Group I (n = 6) was converted directly from ECMO to VAD. Group II (n = 6) underwent stage conversion. We added left atrial drainage to ECMO because of lung edema or marked left heart distension. We discontinued drainage after recovery of right heart function. Group II had more unfavorable risk factors for VAD before ECMO.
Three patients (50%) in Group I received biventricular VADs. The other 3 patients were converted to left ventricular assist device (LVAD), but only 1 (16.7%) experienced successful conversion. We successfully converted 5 patients (83.3%) in Group II to LVAD without right VAD, and 4 of them could be weaned from the ventilator. The multiple-organ dysfunction score gradually improved in Group II despite additional surgery. Two patients in each group received heart transplantation and survived long term.
Using a conversion protocol provides a good guideline for making decisions. According to the protocol, right heart and pulmonary function can be clearly assured before shifting to LVAD in these critical ECMO-supported patients.
体外膜肺氧合(ECMO)因其并发症发生率高,不适合长期支持治疗。从ECMO转换为心室辅助装置(VAD)是合理的,我们已经开发出一种简单的算法,用于为这些接受ECMO支持的患者选择合适的VAD。
我们将12例接受ECMO支持的患者转换为VAD以过渡到移植。第一组(n = 6)直接从ECMO转换为VAD。第二组(n = 6)进行分期转换。由于肺水肿或明显的左心扩张,我们在ECMO上增加了左心房引流。右心功能恢复后停止引流。第二组在ECMO之前有更多不利于VAD的危险因素。
第一组中有3例患者(50%)接受了双心室VAD。其他3例患者转换为左心室辅助装置(LVAD),但只有1例(16.7%)成功转换。我们成功地将第二组中的5例患者(83.3%)转换为无右心室VAD的LVAD,其中4例患者可以脱离呼吸机。尽管进行了额外的手术,但第二组的多器官功能障碍评分逐渐改善。每组中有2例患者接受了心脏移植并长期存活。
使用转换方案为决策提供了良好的指导。根据该方案,在这些接受ECMO支持的重症患者转换为LVAD之前,可以明确确保右心和肺功能。